Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
Letter of Support for FY2027 Funding for NBS Programs
-
Medical Society Letter about Anthem Policy on Use of Nonparticipating Care Providers
-
Stakeholder Letter Opposing the Patent Eligibility Restoration Act (PERA)
-
Sign-on Letter Urging Reinstatement of the ACHDNC
-
Sign-on Letter to Evicore Regarding Interpretation of NCCN Guidelines
-
ACMG Response to PLUGS on Framework for Development of Payer Medical Necessity Policy
-
Sign-on Letter Opposing the Patent Eligibility Restoraction Act of 2024
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases